Telemetry Investments’s ADMA Biologics ADMA Stock Holding History

Telemetry Investments’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$223K	Sell	57,500 -15,000	-21%	-$46.3K	0.35%	69
2022 Q3	$176K	Sell	72,500 -27,500	-28%	-$66K	0.23%	105
2022 Q2	$198K	Sell	100,000 -132,500	-57%	-$261K	0.23%	105
2022 Q1	$425K	Sell	232,500 -27,500	-11%	-$42.9K	0.67%	54
2021 Q4	$367K	Buy	260,000 +200,000	+333%	+$263K	0.47%	72
2021 Q3	$68K	Buy	+60,000	New	+$84K	0.09%	140
2021 Q1	–	Sell	-200,615	Closed	-$391K	–	127
2020 Q4	$391K	Buy	200,615 +4,000	+2%	+$8.41K	0.66%	57
2020 Q3	$470K	Sell	196,615 -83,526	-30%	-$229K	1.02%	42
2020 Q2	$821K	Sell	280,141 -10,620	-4%	-$30.5K	2.23%	12
2020 Q1	$837K	Buy	290,761 +138,761	+91%	+$480K	2.92%	7
2019 Q4	$608K	Buy	152,000 +88,000	+138%	+$384K	2.03%	19
2019 Q3	$285K	Sell	64,000 -47,005	-42%	-$196K	0.82%	34
2019 Q2	$430K	Buy	+111,005	New	+$490K	0.33%	49
2016 Q4	–	Sell	-10,000	Closed	-$72K	–	104
2016 Q3	$72K	Sell	10,000 -40,000	-80%	-$254K	0.05%	107
2016 Q2	$298K	Buy	50,000 +3,000	+6%	+$21K	0.16%	69
2016 Q1	$380K	Buy	47,000 +2,000	+4%	+$11.4K	0.11%	70
2015 Q4	$365K	Sell	45,000 -1,987	-4%	-$17.9K	0.12%	91
2015 Q3	$393K	Sell	46,987 -33,900	-42%	-$313K	0.17%	90
2015 Q2	$749K	Buy	80,887 +3,587	+5%	+$31K	0.34%	64
2015 Q1	$758K	Buy	77,300 +10,234	+15%	+$103K	0.42%	49
2014 Q4	$749K	Buy	+67,066	New	+$767K	0.46%	59

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Telemetry Investments's ADMA Position: Q4 2022 in Review

Telemetry Investments reduced its ADMA Biologics (ADMA) stake by 21% in Q4 2022, selling an estimated $46.3K and leaving 57,500 shares worth $223K. The position accounts for 0.35% of the portfolio, ranked #69.

Telemetry Investments first reported a position in ADMA in Q4 2014 and has held it in 21 quarters since. The position peaked at $837K in Q1 2020. 159 funds tracked by Wall St. Rank hold ADMA as of Q4 2022.

Telemetry Investments held 57,500 shares of ADMA Biologics worth $223K as of Q4 2022.
Telemetry Investments sold 15,000 ADMA Biologics shares in Q4 2022, an estimated $46.3K.
ADMA Biologics made up 0.35% of Telemetry Investments's portfolio in Q4 2022, its #69 holding.
Telemetry Investments first reported a position in ADMA Biologics in Q4 2014 and has held it in 21 quarters since.
Telemetry Investments's ADMA Biologics position peaked at $837K in Q1 2020.
159 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.